SOURCE: iiBIG

iiBIG

December 07, 2010 10:00 ET

Over 35 Pharma, Biotech Leaders Headline iiBIG's Pharma, Biotech Licensing & Partnering San Diego Summit

PORT WASHINGTON, NY--(Marketwire - December 7, 2010) - iiBIG's Pharma & Biotech Licensing & Partnering -- scheduled for March 3-4, 2011 at the Doubletree Hotel San Diego Downtown in San Diego, CA -- is designed to bring together EVPs, SVPs, Chief Business Officers, COOs and other Senior Management from Pharmaceutical and Biotech companies involved in licensing, business development and strategic alliances and partnerships. This educational and networking forum will provide insight and guidance to pharmaceutical licensing, business development and deal making executives from across the world -- covering issues that will help pharmaceutical companies both large and small to structure the best deals, carefully monitor risks and, perhaps, find their next partner. Executives from across the country will gather together to exchange ideas and information. 

Key issues to be addressed include:

  • What are the best practice strategies in developing an effective win-win licensing deal?
  • Early versus Late Stage Partnering Opportunities
  • Role of Corporate Investors in Today's Deals
  • The Evolving Business Model of Building a Biotech
  • What Uncertain Financial Markets Mean for Deal-Making
  • Maximizing Your Company Value Through Non-Traditional Alliances

Hear from representatives of large, medium, and small pharmaceutical as well as biotechnology companies as they share their insights on the evolving state of the industry. Some key faculty speakers include:

  • Michael Shih, Senior Director, Business Development, Eisai Inc.

  • Dr. Robert Baughman, PharmD PhD, Vice President Experimental Pharmacology, MannKind Corporation

  • Linda A. Egger, PhD, CLP™, Senior Director, Scientific Liaison External Scientific Affairs - Diabetes and Obesity Licensing, Merck & Co.

  • Dr. Sameeh M. Salama, Senior Director, Business Development, NAEJA Pharmaceutical Inc.

  • Christoph Pittius, Ph. D., Executive Director, Business Development & Licensing, Novartis Oncology

  • Daisy Rivera-Muzzio, Senior Director EP Product Licensing, Portfolio Development, Pfizer

  • Allen Downs, Senior Executive Director, Licensing & Business Development, Purdue Pharma

  • Michael D. Step, Senior VP, Corporate Development, Santarus, Inc.

  • Gwen Melincoff, Senior Vice President of Business Development, Shire Pharmaceuticals

For complete information about this event visit: http://www.iibig.com/P1101.

About iiBIG
iiBIG (International Institute for Business Information & Growth) is an unbiased, independent company dedicated to organizing business-to-business conferences and seminars for senior-level business executives. For more information, visit: http://www.iibig.com

Contact Information